As per corporate shareholdings filed for Jan-2025, people matching iShares Nasdaq US Biotechnology ETF publicly holds 284 stocks with a net worth of over US$ 577.5 M.
These are shares held by iShares Nasdaq US Biotechnology ETF as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
---|---|---|---|---|---|---|---|---|
Abcam - ADR (Sponsored) | Ishares Nasdaq Us Biotechnology Etf | 0.00 | 98,831 | 0.04% | 0.00 | - | ||
Seagen Inc | Ishares Nasdaq Us Biotechnology Etf | 228.88 | 86,200 | 0.05% | 0.00 | 19.7 M | ||
EQRx Inc | Ishares Nasdaq Us Biotechnology Etf | 0.00 | 230,989 | 0.05% | 0.00 | - | ||
Horizon Therapeutics Plc | Ishares Nasdaq Us Biotechnology Etf | 116.30 | 99,504 | 0.04% | 0.00 | 11.6 M | ||
Intercept Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 0.00 | 17,882 | 0.04% | 0.00 | - | ||
Reata Pharmaceuticals Inc - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 172.36 | 15,442 | 0.04% | 0.00 | 2.7 M | ||
Mirati Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 58.70 | 34,478 | 0.05% | 0.00 | 2.0 M | ||
Gracell Biotechnologies Inc - ADR | Ishares Nasdaq Us Biotechnology Etf | 0.00 | 35,999 | 0.04% | 0.00 | - | ||
Immunogen, Inc. | Ishares Nasdaq Us Biotechnology Etf | 31.23 | 134,116 | 0.05% | 0.00 | 4.2 M | ||
Cymabay Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 32.48 | 58,215 | 0.05% | 0.00 | 1.9 M | ||
Karuna Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 329.83 | 19,242 | 0.05% | 0.00 | 6.3 M | ||
Alpine Immune Sciences Inc | Ishares Nasdaq Us Biotechnology Etf | 7.80 | 34,505 | 0.05% | 0.00 | 269.1 K | ||
Deciphera Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 25.59 | 43,390 | 0.05% | 0.00 | 1.1 M | ||
Fusion Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 0.00 | 39,230 | 0.05% | 0.00 | - | ||
Morphic Holding Inc | Ishares Nasdaq Us Biotechnology Etf | 56.99 | 31,539 | 0.06% | 0.00 | 1.8 M | ||
PetIQ Inc - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 30.98 | 16,330 | 0.06% | 0.00 | 505.9 K | ||
Reneo Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 18.20 | 23,215 | 0.07% | 0.00 | 422.5 K | ||
Exscientia Plc - ADR | Ishares Nasdaq Us Biotechnology Etf | 4.84 | 29,062 | 0.02% | 0.00 | 140.7 K | ||
BeiGene Ltd - ADR | Ishares Nasdaq Us Biotechnology Etf | 261.10 | 21,327 | 0.02% | 0.00 | 5.6 M | ||
Revance Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 3.65 | 55,366 | 0.05% | 0.00 | 202.1 K | ||
AbCellera Biologics Inc | Ishares Nasdaq Us Biotechnology Etf | 2.59 | 147,247 | 0.05% | 0.00 | 381.4 K | ||
Adma Biologics Inc | Ishares Nasdaq Us Biotechnology Etf | 20.32 | 117,776 | 0.05% | 0.00 | 2.4 M | ||
Altimmune Inc | Ishares Nasdaq Us Biotechnology Etf | 6.05 | 35,474 | 0.05% | NEW | 214.6 K | ||
Amylyx Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 3.78 | 35,182 | 0.04% | -0.01 | 133.0 K | ||
Amphastar Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 28.46 | 23,955 | 0.05% | 0.00 | 681.8 K | ||
ANI Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 65.98 | 10,471 | 0.05% | -0.01 | 690.9 K | ||
BridgeBio Pharma Inc | Ishares Nasdaq Us Biotechnology Etf | 37.22 | 94,150 | 0.05% | 0.00 | 3.5 M | ||
Biogen Inc | Ishares Nasdaq Us Biotechnology Etf | 141.60 | 72,751 | 0.05% | 0.00 | 10.3 M | ||
Codexis Inc. | Ishares Nasdaq Us Biotechnology Etf | 3.07 | 40,601 | 0.05% | NEW | 124.6 K | ||
Collegium Pharmaceutical Inc | Ishares Nasdaq Us Biotechnology Etf | 30.56 | 16,072 | 0.05% | 0.00 | 491.2 K | ||
Castle Biosciences Inc | Ishares Nasdaq Us Biotechnology Etf | 20.98 | 13,959 | 0.05% | 0.00 | 292.9 K | ||
Dynavax Technologies Corp. | Ishares Nasdaq Us Biotechnology Etf | 13.84 | 65,501 | 0.05% | 0.00 | 906.5 K | ||
4D Molecular Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 3.93 | 23,058 | 0.05% | -0.01 | 90.6 K | ||
Fortrea Holdings Inc | Ishares Nasdaq Us Biotechnology Etf | 9.40 | 43,141 | 0.05% | -0.01 | 405.5 K | ||
Immunovant Inc | Ishares Nasdaq Us Biotechnology Etf | 19.44 | 73,127 | 0.04% | -0.01 | 1.4 M | ||
Intra-Cellular Therapies Inc | Ishares Nasdaq Us Biotechnology Etf | 131.70 | 53,113 | 0.05% | 0.00 | 7.0 M | ||
KalVista Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 12.25 | 24,038 | 0.05% | 0.00 | 294.5 K | ||
Medpace Holdings Inc | Ishares Nasdaq Us Biotechnology Etf | 330.59 | 15,488 | 0.05% | 0.00 | 5.1 M | ||
Mirum Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 47.02 | 23,913 | 0.05% | 0.00 | 1.1 M | ||
Moderna Inc | Ishares Nasdaq Us Biotechnology Etf | 34.17 | 192,335 | 0.05% | 0.00 | 6.6 M | ||
Nuvalent Inc - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 77.14 | 32,944 | 0.05% | 0.00 | 2.5 M | ||
Rigel Pharmaceuticals | Ishares Nasdaq Us Biotechnology Etf | 20.54 | 8,781 | 0.05% | NEW | 180.4 K | ||
Sana Biotechnology Inc | Ishares Nasdaq Us Biotechnology Etf | 2.42 | 106,932 | 0.05% | -0.01 | 258.8 K | ||
Sarepta Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 76.33 | 47,579 | 0.05% | 0.00 | 3.6 M | ||
Supernus Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 32.70 | 27,515 | 0.05% | 0.00 | 899.7 K | ||
Tarsus Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 52.36 | 19,045 | 0.05% | 0.00 | 997.2 K | ||
Twist Bioscience Corp | Ishares Nasdaq Us Biotechnology Etf | 44.94 | 29,570 | 0.05% | 0.00 | 1.3 M | ||
Veracyte Inc | Ishares Nasdaq Us Biotechnology Etf | 33.16 | 38,606 | 0.05% | 0.00 | 1.3 M | ||
Viatris Inc | Ishares Nasdaq Us Biotechnology Etf | 9.30 | 596,590 | 0.05% | 0.00 | 5.5 M | ||
Absci Corp | Ishares Nasdaq Us Biotechnology Etf | 3.10 | 57,291 | 0.04% | NEW | 177.6 K | ||
Arbutus Biopharma Corp | Ishares Nasdaq Us Biotechnology Etf | 3.39 | 94,495 | 0.05% | 0.00 | 320.3 K | ||
Acadia Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 17.23 | 82,899 | 0.05% | 0.00 | 1.4 M | ||
AC Immune SA | Ishares Nasdaq Us Biotechnology Etf | 2.12 | 52,121 | 0.05% | 0.00 | 110.5 K | ||
Arcellx Inc | Ishares Nasdaq Us Biotechnology Etf | 72.48 | 26,932 | 0.05% | 0.00 | 2.0 M | ||
Acrivon Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 5.61 | 15,536 | 0.05% | NEW | 87.2 K | ||
Adaptive Biotechnologies Corp | Ishares Nasdaq Us Biotechnology Etf | 8.66 | 73,550 | 0.05% | -0.01 | 636.9 K | ||
Agios Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 32.31 | 28,420 | 0.05% | 0.00 | 918.3 K | ||
Akero Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 45.08 | 34,771 | 0.04% | -0.01 | 1.6 M | ||
Alector Inc | Ishares Nasdaq Us Biotechnology Etf | 1.37 | 55,478 | 0.06% | 0.00 | 76.0 K | ||
Alkermes plc | Ishares Nasdaq Us Biotechnology Etf | 34.79 | 80,603 | 0.05% | -0.01 | 2.8 M | ||
Allogene Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 1.68 | 100,983 | 0.05% | -0.01 | 169.7 K | ||
Alumis Inc. | Ishares Nasdaq Us Biotechnology Etf | 3.78 | 23,558 | 0.04% | NEW | 89.0 K | ||
Alnylam Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 290.70 | 64,357 | 0.05% | 0.00 | 18.7 M | ||
Alvotech | Ishares Nasdaq Us Biotechnology Etf | 11.56 | 132,938 | 0.04% | NEW | 1.5 M | ||
AMGEN Inc. | Ishares Nasdaq Us Biotechnology Etf | 314.38 | 152,610 | 0.03% | 0.00 | 48.0 M | ||
Amarin Corp - ADR | Ishares Nasdaq Us Biotechnology Etf | 0.46 | 229,057 | 0.06% | 0.00 | 105.4 K | ||
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 8.89 | 154,375 | 0.05% | NEW | 1.4 M | ||
AnaptysBio Inc | Ishares Nasdaq Us Biotechnology Etf | 18.71 | 14,891 | 0.05% | 0.00 | 278.6 K | ||
Annexon Inc | Ishares Nasdaq Us Biotechnology Etf | 2.70 | 53,193 | 0.05% | NEW | 143.6 K | ||
Apogee Therapeutics Inc. | Ishares Nasdaq Us Biotechnology Etf | 40.84 | 22,438 | 0.04% | 0.00 | 916.4 K | ||
Apellis Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 24.26 | 61,971 | 0.05% | 0.00 | 1.5 M | ||
Applied Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 0.56 | 58,062 | 0.05% | NEW | 32.5 K | ||
Aquestive Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 3.25 | 45,496 | 0.05% | NEW | 147.9 K | ||
Arcturus Therapeutics Holdings Inc | Ishares Nasdaq Us Biotechnology Etf | 13.27 | 13,108 | 0.05% | -0.01 | 173.9 K | ||
Ardelyx Inc | Ishares Nasdaq Us Biotechnology Etf | 5.25 | 118,041 | 0.05% | 0.00 | 619.7 K | ||
Argen X SE - ADR | Ishares Nasdaq Us Biotechnology Etf | 607.95 | 16,094 | 0.03% | 0.00 | 9.8 M | ||
Arcutis Biotherapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 17.29 | 58,331 | 0.05% | 0.00 | 1.0 M | ||
Artiva Biotherapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 3.91 | 12,111 | 0.05% | NEW | 47.4 K | ||
Arvinas Inc | Ishares Nasdaq Us Biotechnology Etf | 8.61 | 34,250 | 0.05% | 0.00 | 294.9 K | ||
Arrowhead Pharmaceuticals Inc. | Ishares Nasdaq Us Biotechnology Etf | 15.50 | 62,000 | 0.05% | -0.01 | 961 K | ||
Ascendis Pharma A/S - ADR | Ishares Nasdaq Us Biotechnology Etf | 167.99 | 30,041 | 0.05% | 0.00 | 5.0 M | ||
Astria Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 6.37 | 28,156 | 0.05% | NEW | 179.4 K | ||
Aurinia Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 8.53 | 71,362 | 0.05% | 0.00 | 608.7 K | ||
Aura Biosciences Inc | Ishares Nasdaq Us Biotechnology Etf | 7.00 | 24,915 | 0.05% | NEW | 174.4 K | ||
Autolus Therapeutics plc - ADR | Ishares Nasdaq Us Biotechnology Etf | 1.71 | 98,112 | 0.04% | 0.00 | 167.8 K | ||
ArriVent BioPharma Inc. | Ishares Nasdaq Us Biotechnology Etf | 20.21 | 16,791 | 0.05% | NEW | 339.3 K | ||
Avadel Pharmaceuticals plc - ADR | Ishares Nasdaq Us Biotechnology Etf | 8.53 | 48,042 | 0.05% | 0.00 | 409.8 K | ||
Atea Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 3.20 | 43,743 | 0.05% | 0.00 | 140.0 K | ||
Anavex Life Sciences Corporation | Ishares Nasdaq Us Biotechnology Etf | 9.61 | 42,275 | 0.05% | -0.01 | 406.3 K | ||
Axsome Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 129.17 | 24,144 | 0.05% | 0.00 | 3.1 M | ||
Astrazeneca plc - ADR | Ishares Nasdaq Us Biotechnology Etf | 74.09 | 290,520 | 0.01% | 0.00 | 21.5 M | ||
Biocryst Pharmaceuticals Inc. | Ishares Nasdaq Us Biotechnology Etf | 8.05 | 103,221 | 0.05% | 0.00 | 830.9 K | ||
Bicycle Therapeutics Plc - ADR | Ishares Nasdaq Us Biotechnology Etf | 9.20 | 21,945 | 0.03% | 0.00 | 201.9 K | ||
Beam Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 24.01 | 41,255 | 0.05% | 0.00 | 990.5 K | ||
Biomea Fusion Inc | Ishares Nasdaq Us Biotechnology Etf | 2.79 | 19,671 | 0.05% | 0.00 | 54.9 K | ||
Biomarin Pharmaceutical Inc. - Registered Shares | Ishares Nasdaq Us Biotechnology Etf | 71.99 | 95,315 | 0.05% | 0.00 | 6.9 M | ||
BioNTech SE - ADR | Ishares Nasdaq Us Biotechnology Etf | 100.64 | 49,126 | 0.02% | 0.00 | 4.9 M | ||
Blueprint Medicines Corp | Ishares Nasdaq Us Biotechnology Etf | 95.27 | 31,642 | 0.05% | 0.00 | 3.0 M | ||
C4 Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 2.22 | 35,215 | 0.05% | NEW | 78.2 K | ||
Cullinan Oncology Inc | Ishares Nasdaq Us Biotechnology Etf | 8.54 | 29,042 | 0.05% | 0.00 | 248.0 K | ||
Cg Oncology Inc. | Ishares Nasdaq Us Biotechnology Etf | 28.53 | 33,694 | 0.04% | NEW | 961.3 K | ||
Climb Bio Inc. | Ishares Nasdaq Us Biotechnology Etf | 1.32 | 33,541 | 0.05% | NEW | 44.3 K | ||
Compass Pathways Plc - ADR | Ishares Nasdaq Us Biotechnology Etf | 3.11 | 25,360 | 0.03% | NEW | 78.9 K | ||
Centessa Pharmaceuticals plc - ADR | Ishares Nasdaq Us Biotechnology Etf | 16.63 | 44,440 | 0.03% | 0.00 | 739.0 K | ||
Cogent Biosciences Inc | Ishares Nasdaq Us Biotechnology Etf | 7.40 | 55,065 | 0.05% | 0.00 | 407.5 K | ||
CARGO Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 4.20 | 22,962 | 0.05% | NEW | 96.4 K | ||
CorMedix Inc | Ishares Nasdaq Us Biotechnology Etf | 10.77 | 30,249 | 0.05% | NEW | 325.8 K | ||
Crinetics Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 35.94 | 46,199 | 0.05% | 0.00 | 1.7 M | ||
CRISPR Therapeutics AG | Ishares Nasdaq Us Biotechnology Etf | 42.62 | 42,524 | 0.05% | 0.00 | 1.8 M | ||
Corvus Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 4.25 | 32,060 | 0.05% | NEW | 136.3 K | ||
CureVac N.V. | Ishares Nasdaq Us Biotechnology Etf | 3.00 | 111,846 | 0.05% | 0.00 | 335.5 K | ||
Cytokinetics Inc | Ishares Nasdaq Us Biotechnology Etf | 46.57 | 58,796 | 0.05% | 0.00 | 2.7 M | ||
Day One Biopharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 8.31 | 50,266 | 0.05% | 0.00 | 417.7 K | ||
Denali Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 14.76 | 71,707 | 0.05% | 0.00 | 1.1 M | ||
Design Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 4.93 | 28,249 | 0.05% | NEW | 139.3 K | ||
Dyne Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 12.39 | 50,713 | 0.04% | -0.01 | 628.3 K | ||
Editas Medicine Inc | Ishares Nasdaq Us Biotechnology Etf | 1.39 | 42,808 | 0.05% | 0.00 | 59.5 K | ||
Enliven Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 22.46 | 24,348 | 0.05% | 0.00 | 546.9 K | ||
Enanta Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 6.20 | 10,567 | 0.05% | NEW | 65.5 K | ||
Evolus Inc | Ishares Nasdaq Us Biotechnology Etf | 13.00 | 31,567 | 0.05% | 0.00 | 410.4 K | ||
Erasca Inc | Ishares Nasdaq Us Biotechnology Etf | 1.49 | 141,069 | 0.05% | 0.00 | 210.2 K | ||
Esperion Therapeutics Inc. | Ishares Nasdaq Us Biotechnology Etf | 1.74 | 98,304 | 0.05% | NEW | 171.0 K | ||
89bio Inc | Ishares Nasdaq Us Biotechnology Etf | 9.15 | 57,878 | 0.04% | -0.01 | 529.6 K | ||
Edgewise Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 23.37 | 47,179 | 0.05% | 0.00 | 1.1 M | ||
Exelixis Inc | Ishares Nasdaq Us Biotechnology Etf | 37.72 | 142,997 | 0.05% | 0.00 | 5.4 M | ||
EyePoint Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 6.34 | 34,047 | 0.05% | 0.01 | 215.9 K | ||
Fate Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 0.94 | 56,823 | 0.05% | NEW | 53.4 K | ||
Foghorn Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 4.22 | 27,738 | 0.05% | NEW | 117.1 K | ||
Amicus Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 8.69 | 148,881 | 0.05% | 0.00 | 1.3 M | ||
Geron Corp. | Ishares Nasdaq Us Biotechnology Etf | 1.75 | 301,255 | 0.05% | -0.01 | 527.2 K | ||
Guardant Health Inc | Ishares Nasdaq Us Biotechnology Etf | 46.74 | 61,548 | 0.05% | 0.00 | 2.9 M | ||
Gilead Sciences, Inc. | Ishares Nasdaq Us Biotechnology Etf | 106.74 | 466,270 | 0.04% | -0.01 | 49.8 M | ||
Galapagos NV - ADR | Ishares Nasdaq Us Biotechnology Etf | 25.95 | 6,977 | 0.01% | -0.01 | 181.1 K | ||
Monte Rosa Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 5.83 | 30,648 | 0.05% | NEW | 178.7 K | ||
Genmab - ADR | Ishares Nasdaq Us Biotechnology Etf | 19.29 | 20,901 | 0.00% | 0.00 | 403.2 K | ||
Structure Therapeutics Inc - ADR | Ishares Nasdaq Us Biotechnology Etf | 21.05 | 29,692 | 0.05% | 0.00 | 625.0 K | ||
GRAIL Inc. | Ishares Nasdaq Us Biotechnology Etf | 32.13 | 16,961 | 0.05% | 0.00 | 545.0 K | ||
Grifols SA - ADR - Level III | Ishares Nasdaq Us Biotechnology Etf | 7.75 | 58,673 | 0.01% | 0.00 | 454.7 K | ||
Halozyme Therapeutics Inc. | Ishares Nasdaq Us Biotechnology Etf | 64.02 | 63,378 | 0.05% | 0.00 | 4.1 M | ||
HUTCHMED (China) Limited - ADR | Ishares Nasdaq Us Biotechnology Etf | 15.09 | 15,071 | 0.01% | 0.00 | 227.4 K | ||
Harmony Biosciences Holdings Inc | Ishares Nasdaq Us Biotechnology Etf | 34.24 | 28,406 | 0.05% | 0.00 | 972.6 K | ||
Harrow Health Inc | Ishares Nasdaq Us Biotechnology Etf | 30.00 | 17,747 | 0.05% | 0.00 | 532.4 K | ||
Humacyte Inc | Ishares Nasdaq Us Biotechnology Etf | 3.32 | 65,050 | 0.05% | 0.00 | 216.0 K | ||
ImmunityBio Inc | Ishares Nasdaq Us Biotechnology Etf | 2.85 | 347,210 | 0.04% | -0.01 | 989.5 K | ||
Ideaya Biosciences Inc | Ishares Nasdaq Us Biotechnology Etf | 18.59 | 43,067 | 0.05% | 0.00 | 800.6 K | ||
IGM Biosciences Inc | Ishares Nasdaq Us Biotechnology Etf | 1.26 | 16,994 | 0.03% | NEW | 21.4 K | ||
Illumina Inc | Ishares Nasdaq Us Biotechnology Etf | 88.02 | 79,006 | 0.05% | 0.00 | 7.0 M | ||
Immunocore Holdings plc - ADR | Ishares Nasdaq Us Biotechnology Etf | 29.64 | 19,720 | 0.04% | 0.00 | 584.5 K | ||
Incyte Corp. | Ishares Nasdaq Us Biotechnology Etf | 62.78 | 96,327 | 0.05% | 0.00 | 6.0 M | ||
Indivior Plc | Ishares Nasdaq Us Biotechnology Etf | 10.10 | 67,944 | 0.05% | NEW | 686.2 K | ||
Insmed Inc | Ishares Nasdaq Us Biotechnology Etf | 79.38 | 89,114 | 0.05% | 0.00 | 7.1 M | ||
Innoviva Inc | Ishares Nasdaq Us Biotechnology Etf | 17.33 | 31,199 | 0.05% | 0.00 | 540.7 K | ||
Inhibrx Biosciences Inc. | Ishares Nasdaq Us Biotechnology Etf | 13.94 | 7,226 | 0.05% | NEW | 100.7 K | ||
Inozyme Pharma Inc | Ishares Nasdaq Us Biotechnology Etf | 1.01 | 32,051 | 0.05% | NEW | 32.4 K | ||
Ionis Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 33.45 | 78,659 | 0.05% | 0.00 | 2.6 M | ||
Iovance Biotherapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 3.63 | 151,886 | 0.05% | -0.01 | 551.3 K | ||
Disc Medicine Inc | Ishares Nasdaq Us Biotechnology Etf | 53.70 | 14,831 | 0.04% | -0.01 | 796.4 K | ||
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 1.49 | 79,666 | 0.05% | 0.00 | 118.7 K | ||
ITeos Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 6.89 | 17,836 | 0.05% | -0.01 | 122.9 K | ||
Janux Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 31.74 | 26,145 | 0.04% | -0.01 | 829.8 K | ||
Jazz Pharmaceuticals plc | Ishares Nasdaq Us Biotechnology Etf | 142.02 | 30,109 | 0.05% | -0.01 | 4.3 M | ||
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 23.41 | 20,719 | 0.03% | 0.00 | 485.0 K | ||
Keros Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 11.44 | 20,541 | 0.05% | 0.00 | 235.0 K | ||
Krystal Biotech Inc | Ishares Nasdaq Us Biotechnology Etf | 194.44 | 14,327 | 0.05% | 0.00 | 2.8 M | ||
Kura Oncology Inc | Ishares Nasdaq Us Biotechnology Etf | 7.65 | 38,778 | 0.05% | 0.00 | 296.7 K | ||
Kymera Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 33.70 | 32,269 | 0.05% | 0.00 | 1.1 M | ||
Kyverna Therapeutics Inc. | Ishares Nasdaq Us Biotechnology Etf | 2.35 | 21,534 | 0.05% | NEW | 50.6 K | ||
Legend Biotech Corp - ADR | Ishares Nasdaq Us Biotechnology Etf | 36.33 | 40,694 | 0.02% | 0.00 | 1.5 M | ||
LENZ Therapeutics Inc. | Ishares Nasdaq Us Biotechnology Etf | 26.66 | 13,710 | 0.05% | NEW | 365.5 K | ||
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B | Ishares Nasdaq Us Biotechnology Etf | 111.67 | 9,418 | 0.05% | 0.00 | 1.1 M | ||
Larimar Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 2.28 | 31,843 | 0.05% | NEW | 72.6 K | ||
Lexeo Therapeutics Inc. | Ishares Nasdaq Us Biotechnology Etf | 4.09 | 16,497 | 0.05% | NEW | 67.5 K | ||
Lexicon Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 0.36 | 197,383 | 0.05% | 0.00 | 71.1 K | ||
Lyell Immunopharma Inc | Ishares Nasdaq Us Biotechnology Etf | 0.56 | 142,791 | 0.05% | 0.00 | 80.0 K | ||
Madrigal Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 346.40 | 10,864 | 0.05% | 0.00 | 3.8 M | ||
Mesoblast Ltd - ADR | Ishares Nasdaq Us Biotechnology Etf | 14.39 | 15,933 | 0.01% | NEW | 229.3 K | ||
Macrogenics Inc | Ishares Nasdaq Us Biotechnology Etf | 1.96 | 32,160 | 0.05% | 0.00 | 63.0 K | ||
MeiraGTx Holdings plc | Ishares Nasdaq Us Biotechnology Etf | 7.69 | 38,015 | 0.05% | 0.00 | 292.3 K | ||
Mineralys Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 16.17 | 24,817 | 0.05% | 0.00 | 401.3 K | ||
Mannkind Corp | Ishares Nasdaq Us Biotechnology Etf | 5.23 | 137,431 | 0.05% | -0.01 | 718.8 K | ||
Mind Medicine Inc | Ishares Nasdaq Us Biotechnology Etf | 6.92 | 36,579 | 0.05% | NEW | 253.1 K | ||
Mersana Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 0.44 | 61,635 | 0.05% | NEW | 27.1 K | ||
Merus N.V | Ishares Nasdaq Us Biotechnology Etf | 48.77 | 34,104 | 0.05% | 0.00 | 1.7 M | ||
Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 2.24 | 70,741 | 0.05% | 0.00 | 158.5 K | ||
MaxCyte Inc | Ishares Nasdaq Us Biotechnology Etf | 3.15 | 55,826 | 0.05% | 0.00 | 175.9 K | ||
NewAmsterdam Pharma Company NV | Ishares Nasdaq Us Biotechnology Etf | 24.00 | 46,029 | 0.04% | NEW | 1.1 M | ||
Neurocrine Biosciences, Inc. | Ishares Nasdaq Us Biotechnology Etf | 115.60 | 50,618 | 0.05% | 0.00 | 5.9 M | ||
Neurogene Inc | Ishares Nasdaq Us Biotechnology Etf | 13.96 | 7,408 | 0.05% | NEW | 103.4 K | ||
Nkarta Inc | Ishares Nasdaq Us Biotechnology Etf | 1.55 | 35,205 | 0.05% | NEW | 54.6 K | ||
Neumora Therapeutics Inc. | Ishares Nasdaq Us Biotechnology Etf | 1.20 | 80,611 | 0.05% | NEW | 96.7 K | ||
Nurix Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 13.34 | 35,210 | 0.05% | 0.00 | 469.7 K | ||
Intellia Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 9.31 | 50,774 | 0.05% | 0.00 | 472.7 K | ||
Novavax, Inc. | Ishares Nasdaq Us Biotechnology Etf | 7.69 | 79,836 | 0.05% | 0.00 | 613.9 K | ||
NovoCure Ltd | Ishares Nasdaq Us Biotechnology Etf | 19.78 | 53,911 | 0.05% | 0.00 | 1.1 M | ||
OmniAb Inc | Ishares Nasdaq Us Biotechnology Etf | 2.54 | 64,307 | 0.05% | 0.00 | 163.3 K | ||
Ocular Therapeutix Inc | Ishares Nasdaq Us Biotechnology Etf | 7.62 | 78,359 | 0.05% | 0.00 | 597.1 K | ||
OnKure Therapeutics Inc. - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 4.96 | 6,316 | 0.05% | 0.03 | 31.3 K | ||
Olema Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 4.32 | 30,579 | 0.04% | -0.01 | 132.1 K | ||
Omeros Corporation | Ishares Nasdaq Us Biotechnology Etf | 9.02 | 28,909 | 0.05% | NEW | 260.8 K | ||
BeiGene Ltd - ADR | Ishares Nasdaq Us Biotechnology Etf | 253.20 | 22,086 | 0.02% | NEW | 5.6 M | ||
ORIC Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 7.37 | 34,544 | 0.05% | 0.00 | 254.6 K | ||
Oruka Therapeutics Inc. | Ishares Nasdaq Us Biotechnology Etf | 12.36 | 17,461 | 0.05% | NEW | 215.8 K | ||
Pacific Biosciences of California Inc | Ishares Nasdaq Us Biotechnology Etf | 1.33 | 133,102 | 0.04% | 0.00 | 177.0 K | ||
Phibro Animal Health Corp. - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 22.06 | 10,137 | 0.03% | 0.00 | 223.6 K | ||
Pacira BioSciences Inc | Ishares Nasdaq Us Biotechnology Etf | 24.84 | 23,010 | 0.05% | 0.00 | 571.6 K | ||
Vaxcyte Inc | Ishares Nasdaq Us Biotechnology Etf | 73.82 | 62,392 | 0.05% | 0.00 | 4.6 M | ||
PepGen Inc | Ishares Nasdaq Us Biotechnology Etf | 1.70 | 16,260 | 0.05% | NEW | 27.6 K | ||
Precigen Inc | Ishares Nasdaq Us Biotechnology Etf | 1.82 | 145,278 | 0.05% | 0.00 | 264.4 K | ||
Phathom Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 6.55 | 34,116 | 0.05% | 0.00 | 223.5 K | ||
Pliant Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 1.59 | 30,352 | 0.05% | 0.00 | 48.3 K | ||
Praxis Precision Medicines Inc | Ishares Nasdaq Us Biotechnology Etf | 37.71 | 9,283 | 0.05% | NEW | 350.1 K | ||
Prime Medicine Inc | Ishares Nasdaq Us Biotechnology Etf | 2.03 | 65,588 | 0.05% | 0.00 | 133.1 K | ||
Prothena Corporation plc | Ishares Nasdaq Us Biotechnology Etf | 13.34 | 26,827 | 0.05% | 0.00 | 357.9 K | ||
Personalis Inc | Ishares Nasdaq Us Biotechnology Etf | 3.84 | 35,242 | 0.04% | NEW | 135.3 K | ||
PTC Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 57.03 | 38,424 | 0.05% | 0.00 | 2.2 M | ||
Protagonist Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 52.53 | 29,687 | 0.05% | 0.00 | 1.6 M | ||
Pyxis Oncology Inc | Ishares Nasdaq Us Biotechnology Etf | 1.20 | 29,667 | 0.05% | NEW | 35.6 K | ||
Q32 Bio Inc. | Ishares Nasdaq Us Biotechnology Etf | 2.18 | 7,977 | 0.07% | NEW | 17.4 K | ||
uniQure N.V. | Ishares Nasdaq Us Biotechnology Etf | 14.77 | 23,823 | 0.04% | 0.00 | 351.9 K | ||
Rapport Therapeutics Inc. | Ishares Nasdaq Us Biotechnology Etf | 10.22 | 18,246 | 0.05% | NEW | 186.5 K | ||
Ultragenyx Pharmaceutical Inc. | Ishares Nasdaq Us Biotechnology Etf | 39.36 | 46,002 | 0.05% | 0.00 | 1.8 M | ||
Rocket Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 8.73 | 45,441 | 0.04% | -0.01 | 396.7 K | ||
Regeneron Pharmaceuticals, Inc. | Ishares Nasdaq Us Biotechnology Etf | 661.00 | 53,918 | 0.05% | 0.02 | 35.6 M | ||
Replimune Group Inc | Ishares Nasdaq Us Biotechnology Etf | 11.05 | 39,336 | 0.05% | 0.00 | 434.7 K | ||
Regenxbio Inc | Ishares Nasdaq Us Biotechnology Etf | 8.70 | 23,702 | 0.05% | -0.01 | 206.2 K | ||
Relay Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 3.10 | 83,472 | 0.05% | 0.01 | 258.8 K | ||
Avidity Biosciences Inc | Ishares Nasdaq Us Biotechnology Etf | 33.30 | 59,438 | 0.05% | 0.00 | 2.0 M | ||
Cartesian Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 15.94 | 12,676 | 0.05% | NEW | 202.1 K | ||
Roivant Sciences Ltd | Ishares Nasdaq Us Biotechnology Etf | 10.83 | 362,638 | 0.05% | 0.00 | 3.9 M | ||
Royalty Pharma plc - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 33.75 | 221,331 | 0.05% | 0.00 | 7.5 M | ||
Revolution Medicines Inc | Ishares Nasdaq Us Biotechnology Etf | 39.34 | 83,798 | 0.05% | -0.01 | 3.3 M | ||
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 6.79 | 190,208 | 0.05% | 0.00 | 1.3 M | ||
Rhythm Pharmaceuticals Inc. | Ishares Nasdaq Us Biotechnology Etf | 53.72 | 30,614 | 0.05% | 0.00 | 1.6 M | ||
Sage Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 8.21 | 32,334 | 0.05% | 0.00 | 265.5 K | ||
scPharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 3.13 | 24,958 | 0.05% | NEW | 78.1 K | ||
SIGA Technologies Inc | Ishares Nasdaq Us Biotechnology Etf | 5.98 | 35,619 | 0.05% | -0.01 | 213.0 K | ||
Solid Biosciences Inc | Ishares Nasdaq Us Biotechnology Etf | 4.78 | 19,931 | 0.03% | NEW | 95.3 K | ||
Silence Therapeutics Plc - ADR | Ishares Nasdaq Us Biotechnology Etf | 3.49 | 23,435 | 0.05% | NEW | 81.8 K | ||
Acelyrin Inc | Ishares Nasdaq Us Biotechnology Etf | 2.64 | 48,947 | 0.05% | -0.01 | 129.2 K | ||
Summit Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 20.69 | 368,736 | 0.05% | 0.00 | 7.6 M | ||
Syndax Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 13.73 | 42,540 | 0.05% | 0.00 | 584.1 K | ||
Sanofi - ADR | Ishares Nasdaq Us Biotechnology Etf | 55.93 | 149,987 | 0.01% | 0.00 | 8.4 M | ||
ARS Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 12.89 | 48,437 | 0.05% | 0.00 | 624.4 K | ||
Scholar Rock Holding Corp | Ishares Nasdaq Us Biotechnology Etf | 33.81 | 46,635 | 0.05% | 0.00 | 1.6 M | ||
Stoke Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 8.29 | 26,414 | 0.05% | NEW | 219.0 K | ||
Sutro Biopharma Inc | Ishares Nasdaq Us Biotechnology Etf | 0.77 | 41,143 | 0.05% | NEW | 31.7 K | ||
Savara Inc | Ishares Nasdaq Us Biotechnology Etf | 2.83 | 89,934 | 0.05% | 0.00 | 254.5 K | ||
SpringWorks Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 48.51 | 37,056 | 0.05% | 0.00 | 1.8 M | ||
Spyre Therapeutics Inc. | Ishares Nasdaq Us Biotechnology Etf | 19.02 | 29,243 | 0.05% | NEW | 556.2 K | ||
Theravance Biopharma Inc | Ishares Nasdaq Us Biotechnology Etf | 9.39 | 25,804 | 0.05% | 0.00 | 242.3 K | ||
Tscan Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 1.60 | 24,492 | 0.04% | NEW | 39.2 K | ||
Tectonic Therapeutic Inc. | Ishares Nasdaq Us Biotechnology Etf | 21.40 | 7,350 | 0.04% | NEW | 157.3 K | ||
Tempus AI Inc. - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 59.00 | 75,915 | 0.04% | NEW | 4.5 M | ||
Terns Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 3.51 | 43,103 | 0.05% | 0.01 | 151.3 K | ||
Third Harmonic Bio Inc | Ishares Nasdaq Us Biotechnology Etf | 3.62 | 23,051 | 0.05% | 0.00 | 83.4 K | ||
Alpha Teknova Inc | Ishares Nasdaq Us Biotechnology Etf | 6.37 | 26,596 | 0.05% | NEW | 169.4 K | ||
Tango Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 1.74 | 58,361 | 0.05% | 0.00 | 101.5 K | ||
Entrada Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 10.80 | 18,650 | 0.05% | NEW | 201.4 K | ||
Tourmaline Bio Inc | Ishares Nasdaq Us Biotechnology Etf | 17.61 | 12,793 | 0.05% | -0.01 | 225.3 K | ||
Trevi Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 6.40 | 38,354 | 0.04% | NEW | 245.5 K | ||
Taysha Gene Therapies Inc | Ishares Nasdaq Us Biotechnology Etf | 1.66 | 102,269 | 0.05% | -0.01 | 169.8 K | ||
2seventy bio Inc | Ishares Nasdaq Us Biotechnology Etf | 4.96 | 25,746 | 0.05% | NEW | 127.7 K | ||
Tevogen Bio Holdings Inc. | Ishares Nasdaq Us Biotechnology Etf | 1.24 | 87,345 | 0.05% | NEW | 108.3 K | ||
Travere Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 21.29 | 42,965 | 0.05% | 0.00 | 914.7 K | ||
10x Genomics Inc - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 10.39 | 53,322 | 0.04% | NEW | 554.0 K | ||
Tyra Biosciences Inc | Ishares Nasdaq Us Biotechnology Etf | 10.65 | 25,224 | 0.05% | NEW | 268.6 K | ||
UroGen Pharma Ltd | Ishares Nasdaq Us Biotechnology Etf | 11.90 | 20,698 | 0.05% | 0.00 | 246.3 K | ||
United Therapeutics Corp | Ishares Nasdaq Us Biotechnology Etf | 319.86 | 22,309 | 0.05% | 0.00 | 7.1 M | ||
Vericel Corp | Ishares Nasdaq Us Biotechnology Etf | 47.94 | 24,586 | 0.05% | 0.00 | 1.2 M | ||
Vera Therapeutics Inc - Ordinary Shares - Class A | Ishares Nasdaq Us Biotechnology Etf | 27.15 | 31,545 | 0.05% | 0.00 | 856.4 K | ||
Verve Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 5.78 | 44,099 | 0.05% | 0.00 | 254.9 K | ||
Vir Biotechnology Inc | Ishares Nasdaq Us Biotechnology Etf | 7.20 | 68,634 | 0.05% | 0.00 | 494.2 K | ||
Vanda Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 4.82 | 28,255 | 0.05% | -0.01 | 136.2 K | ||
Verona Pharma Plc - ADR | Ishares Nasdaq Us Biotechnology Etf | 66.78 | 36,858 | 0.04% | 0.00 | 2.5 M | ||
Vertex Pharmaceuticals, Inc. | Ishares Nasdaq Us Biotechnology Etf | 511.74 | 92,211 | 0.04% | 0.00 | 47.2 M | ||
Voyager Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 3.91 | 26,813 | 0.05% | -0.01 | 104.8 K | ||
Wave Life Sciences Ltd. | Ishares Nasdaq Us Biotechnology Etf | 10.07 | 76,005 | 0.05% | 0.01 | 765.4 K | ||
Xenon Pharmaceuticals Inc | Ishares Nasdaq Us Biotechnology Etf | 36.45 | 37,978 | 0.05% | 0.00 | 1.4 M | ||
Xeris Biopharma Holdings Inc | Ishares Nasdaq Us Biotechnology Etf | 5.87 | 71,145 | 0.05% | -0.01 | 417.6 K | ||
Xencor Inc | Ishares Nasdaq Us Biotechnology Etf | 12.95 | 35,068 | 0.05% | 0.00 | 454.1 K | ||
Y-Mabs Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 5.16 | 21,948 | 0.05% | -0.01 | 113.3 K | ||
Zai Lab Limited - ADR | Ishares Nasdaq Us Biotechnology Etf | 35.67 | 25,991 | 0.02% | 0.00 | 927.1 K | ||
Zevra Therapeutics Inc | Ishares Nasdaq Us Biotechnology Etf | 8.21 | 26,630 | 0.05% | NEW | 218.6 K | ||
Zymeworks BC Inc | Ishares Nasdaq Us Biotechnology Etf | 13.05 | 34,326 | 0.05% | -0.01 | 448.0 K | ||
ATAI Life Sciences N.V. | 1.57 | - | Investor holds below 1% | |||||
Zentalis Pharmaceuticals Inc | 1.98 | - | Investor holds below 1% | |||||
Ovid Therapeutics Inc | 0.44 | - | Investor holds below 1% | |||||
Ventyx Biosciences Inc | 1.36 | - | Investor holds below 1% | |||||
23andMe Holding Co - Ordinary Shares - Class A | 0.73 | - | Investor holds below 1% | |||||
Myriad Genetics, Inc. | 9.98 | - | Investor holds below 1% | |||||
Bluebird bio Inc | 3.92 | - | Investor holds below 1% | |||||
Caribou Biosciences Inc | 1.02 | - | Investor holds below 1% | |||||
Inhibrx Inc | 14.72 | - | Investor holds below 1% | |||||
Alx Oncology Holdings Inc | 0.69 | - | Investor holds below 1% | |||||
Fulcrum Therapeutics Inc | 3.21 | - | Investor holds below 1% | |||||
RAPT Therapeutics Inc | 1.53 | - | Investor holds below 1% | |||||
Nautilus Biotechnology Inc | 1.00 | - | Investor holds below 1% | |||||
Coherus Biosciences Inc | 0.95 | - | Investor holds below 1% | |||||
Aclaris Therapeutics Inc | 1.70 | - | Investor holds below 1% | |||||
Cabaletta Bio Inc | 1.72 | - | Investor holds below 1% |